Journal Article Summary
The article investigates the formulation and evaluation of solid lipid nanoparticles (SLNs) containing ramipril, an antihypertensive medication used to treat high blood pressure. This research is significant because ramipril has low oral bioavailability and can cause various side effects when administered in traditional forms. By using SLNs as a delivery system, the study aims to improve the drug's absorption and reduce its adverse effects, potentially leading to better therapeutic outcomes for patients.
The researchers prepared SLNs using glyceryl monostearate and glyceryl monooleate as lipid matrices, along with different stabilizers like tween 80, poloxamer 188, and span 20. They evaluated the formulations based on factors such as entrapment efficiency, drug release rates, particle size, and stability. The results showed that the formulation with glyceryl monooleate and span 20 provided the best performance, with a prolonged drug release and smaller particle size compared to other formulations. The entrapment efficiency ranged from 72.50% to 86.40%, indicating that a significant amount of ramipril was successfully incorporated into the nanoparticles.
Despite the promising findings, the study has limitations, including the need for further testing to confirm the safety and effectiveness of these SLNs in clinical settings. Patients should be aware that while SLNs may enhance drug delivery, they are still experimental and not widely available in standard treatments. It is essential for readers to discuss any concerns or questions about ramipril and its formulations with a healthcare professional, especially regarding potential side effects and the best treatment options for their specific health conditions.
Medication Safety Note
This journal article summary is provided for educational purposes only and is not medical advice. Always consult a licensed healthcare professional before starting, stopping, or changing any medication.
Article Cited
- Ekambaram P, Abdul Hasan Sathali A. Formulation and Evaluation of Solid Lipid Nanoparticles of Ramipril. Journal of Young Pharmacists : JYP 2011. DOI: 10.4103/0975-1483.83765. PMID: 21897661. PMCID: PMC3159275.
Featured Pill Pals Product
Ramipril 2.5 mg Capsules --- Generic For Altace --- Rising Pharma
Ramipril 2.5 mg Capsules — Generic For Altace — Rising Pharma is available through Pill Pals Pharmacy with cash-pay pharmacy pricing and free shipping where available. Prescription required.
Request a prescription transfer and our pharmacy team will help coordinate the next step.
